(VIANEWS) - Kilroy Realty Corporation (KRC), PNM Resources (PNM), Amgen (AMGN) are the highest payout ratio stocks on this list.
Here's the data we've collected of stocks with a high payout ratio as yet. The payout ratio in itself isn't a promise of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Kilroy Realty Corporation (KRC)
108.81% Payout Ratio
Kilroy Realty Corporation, NYSE: KRC is the "companyA", A'KRCA" and a prominent West Coast developer and landlord. It has a significant presence in San Diego and Greater Los Angeles as well as the San Francisco Bay Area and the Pacific Northwest. Global recognition has been given to the company for its sustainability, innovative design, and building operations. The company is credited with being pioneers and innovators of sustainable real estate. Its modern approach to business environment helps foster creativity, productivity, and employee retention at some of the most prominent technology, entertainment and business service companies in the world. KRC, which is publicly traded as a real estate investment trust ("A"REITA"), has more than seventy years of combined experience in developing and managing mixed-use office projects. KRC had approximately 13.5 million square feet in its stabilized portfolio, which included primarily office space and life sciences. It was 96% leased and 92.3% of it occupied. There were 200 residential units at KRC in Hollywood, with an average quarterly occupancy of 85.0%. Additionally, there was another 462 units in San Diego which were being leased out. KRC also had eight ongoing development projects totaling $2.0 billion. These included approximately 2.3 Million square feet of office space and life sciences space and 339 residential units. 95% of the office and 90% of life science space were leased.
Earnings per Share
Kilroy Realty Corporation's trailing twelve-month EPS is $1.93.
PE Ratio
Kilroy Realty Corporation's trailing 12 months earnings to price ratio is 20.45. The purchaser of the shares is required to invest $20.45 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is an indicator of the business' profitability relative to shareholders' equity, was 4.49%.Volume
Today's last reported volume for Kilroy Realty Corporation is 338979 which is 67.05% below its average volume of 1028960.
Sales Growth
Kilroy Realty Corporation's sales growth is 6.1% for the ongoing quarter and 5.3% for the next.
2. PNM Resources (PNM)
75% Payout Ratio
Through its subsidiaries, PNM Resources, Inc. engages in energy-related and energy-related business in the United States. The company operates under the Texas-New Mexico Power Company and Public Service Company of New Mexico segments. PNM is the main participant in electricity generation, transmission and distribution. The PNM segment generates electricity from coal, natural gas, oil, nuclear fuel, solar, wind and other energy sources. This segment owned or leased facilities that had a net generation of 2,102 megawatts. It also owned 6,067 miles in distribution overhead lines and 5,885 miles underground distribution lines. There were also 3,206 miles worth of electric transmission lines. The segment also has office equipment and office space that it owns or leases. The TNMP segment offers regulated distribution and transmission services. This segment had 997 miles in overhead electric transmission lines and 7,151 miles in overhead distribution lines as of December 31, 2018. It also owned 1,260 miles underground distribution lines and 122 substations. The company also has vehicles and service facilities that it leases or owns. It serves around 782,000 customers in residential, commercial and industrial settings, as well end-users of electric power in New Mexico, Texas. PNM Resources, Inc. was established in 1917. It is located in Albuquerque, New Mexico.
Earnings Per Share
As for profitability, PNM Resources has a trailing twelve months EPS of $2.51.
PE Ratio
PNM Resources has a trailing twelve months price to earnings ratio of 19.52. Meaning, the purchaser of the share is investing $19.52 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.84%.3. Amgen (AMGN)
60.83% Payout Ratio
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.
Earnings per Share
Amgen's trailing 12 month EPS is $12.07.
PE Ratio
Amgen's trailing 12-month price-earnings ratio is 21.75. The purchaser of the shares is therefore investing $21.75 per dollar in annual earnings.
11.5.16% is the company's return-on-equity, which is a measure of profitability relative to shareholders' equity for twelve months.Sales Growth
Amgen sales growth was negative 1.2% in the most recent quarter, and negative 3.8% in the following.
Moving Average
Amgen's worth is under its 50-day moving average of $275.01 and higher than its 200-day moving average of $251.08.4. CME Group (CME)
53.21% Payout Ratio
CME Group Inc. and its affiliates operate contract markets worldwide for futures trading. Futures and options products are offered based on foreign exchange rates, interest rates, equityindices, foreign currency, agricultural commodities and energy. Fixed income products also available. Clearing house services include clearing, settling and guaranteeing options and futures contracts; cleared swaps products traded on its exchanges; trade processing, risk mitigation and other services. The company also offers market data services that include historical and real-time data. The company serves professionals traders, banks, individual and institutional investors, corporates, as well as manufacturers, suppliers, government, central and local governments. CME Group Inc. was formerly Chicago Mercantile Exchange Holdings Inc. CME Group Inc. was established in 1898. It is located in Chicago, Illinois.
Earnings Per Share
As for profitability, CME Group has a trailing twelve months EPS of $5.33.
PE Ratio
CME Group has a trailing twelve months price to earnings ratio of 31.55. Meaning, the purchaser of the share is investing $31.55 for every dollar of annual earnings.
The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.65%.5. Seacoast Banking Corporation of Florida (SBCF)
30.77% Payout Ratio
Seacoast Banking Corporation of Florida operates as the bank holding company for Seacoast National Bank that provides financial services to retail and commercial customers in Florida. It offers commercial and retail banking, wealth management, and mortgage services; and brokerage and annuity services. The company offers noninterest and interest-bearing demand deposit, money market, savings, and customer sweep accounts; time certificates of deposit; construction and land development, commercial and residential real estate, and commercial and financial loans; and consumer loans, including installment loans and revolving lines, as well as loans for automobiles, boats, and personal or family purposes. As of December 31, 2021, it had 54 branch and commercial lending offices. The company was founded in 1926 and is headquartered in Stuart, Florida.
Earnings per Share
Seacoast Banking Corporation of Florida's trailing twelve-month EPS of $1.98 is a good indicator of profitability.
PE Ratio
Seacoast Banking Corporation of Florida's trailing 12 months earnings to price ratio is 15.19. The purchaser of the shares is therefore investing $15.19 per dollar in annual earnings.
For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability and shareholder equity for a business, was 9.22%.